About
TRIDENT is an international medical research study which aims to determine the effect of more intensive blood pressure (BP) control to prevent recurrent stroke in patients who have had an intracerebral haemorrhage (ICH) (a stroke caused by ruptured… Read More
Learn More
Resources
Stroke Organisations Stroke Foundation (Australia) Stroke Society of Australasia The Stroke Association (United Kingdom) UK Stroke Forum Clinical Guidelines for Stroke Management 2017 Stroke Resources for Professionals – ASA World Stroke Organisation European Stroke Conference Asia Pacific Stroke… Read More
Learn More
For Health Professionals
TRIDENT is a multicentre, international, double-blinded, placebo-controlled, parallel-group, randomised controlled trial of a fixed low-dose combination blood pressure (BP) lowering pill (Triple Pill) on top of standard of care, in patients with a history of acute ICH and… Read More
Learn More